Funds holding VIVOS THERAPEUTICS INC
ISIN US92859E2072 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 395.7K $
- Share of capital
- 2.3 % of 13.9M shares on May 20, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 212,700 | 251K $ | 1.53 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 60,629 | 71.5K $ | 0.00 % | 0.44 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 31,829 | 44.6K $ | 0.00 % | 0.23 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 12,072 | 16.9K $ | 0.09 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 8,350 | 11.7K $ | 0.06 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | -1 | 325,580 | +2.8 % |
| 2026Q1 | 6 | 0 | 316,791 | +165.0 % |
| 2025Q4 | 6 | 0 | 119,565 | +19.6 % |
| 2025Q3 | 6 | 0 | 100,002 | +12.9 % |
| 2025Q2 | 6 | 0 | 88,548 | +97.0 % |
| 2025Q1 | 6 | -1 | 44,947 | +24.6 % |
| 2024Q4 | 7 | +2 | 36,077 | +86.5 % |
| 2024Q3 | 5 | 0 | 19,342 | -0.2 % |
| 2024Q2 | 5 | +1 | 19,389 | +40.6 % |
| 2024Q1 | 4 | 13,789 |
Institutional managers
23 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,115,859 | 1.3M $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 273,329 | 322.5K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 95,543 | 112.7K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 42,500 | 50.2K $ | as of Mar 31, 2026 |
| IHT Wealth Management, LLC | 41,061 | 48.5K $ | as of Mar 31, 2026 |
| B. Riley Wealth Advisors, Inc. | 38,066 | 41.5K $ | as of Mar 31, 2026 |
| Centurion Wealth Management LLC | 35,684 | 42.1K $ | as of Mar 31, 2026 |
| VANGUARD FIDUCIARY TRUST CO | 30,832 | 36.4K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 27,817 | 32.8K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 25,117 | 29.6K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 24,922 | 29.4K $ | as of Mar 31, 2026 |
| Sequoia Financial Advisors, LLC | 24,000 | 28.3K $ | as of Mar 31, 2026 |
| Acorn Wealth Advisors, LLC | 14,776 | 17.4K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 12,511 | 14.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 11,046 | 13K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 7,388 | 8.7K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1,143 | 1.3K $ | as of Mar 31, 2026 |
| SIGNATUREFD, LLC | 547 | 645 $ | as of Mar 31, 2026 |
| Blue Trust, Inc. | 160 | 189 $ | as of Mar 31, 2026 |
| Kozak & Associates, Inc. | 49 | 60 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 7 | 8 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 3 | 4 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of VIVOS THERAPEUTICS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| V-CO Investors LLC and 4 others | 19.90 % | 2,696,123 | as of Mar 31, 2026 · SCHEDULE 13D |
| Armistice Capital, LLC and 1 other | 8.27 % | 1,115,859 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding VIVOS THERAPEUTICS INC". https://titelia.com/en/stocks/vivos-therapeutics-inc-US92859E2072